Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Accounts Payables: 2019-2020

  • Genmab A's Accounts Payables rose 134.75% to $16.8 million in Q4 2020 from the same period last year, while for Dec 2020 it was $16.8 million, marking a year-over-year increase of 134.75%. This contributed to the annual value of $16.8 million for FY2020, which is 134.75% up from last year.
  • Latest data reveals that Genmab A reported Accounts Payables of $16.8 million as of Q4 2020, which was up 134.75% from $7.2 million recorded in Q4 2019.
  • Genmab A's Accounts Payables' 5-year high stood at $16.8 million during Q4 2020, with a 5-year trough of $7.2 million in Q4 2019.
  • Its 2-year average for Accounts Payables is $12.0 million, with a median of $12.0 million in 2020.
  • Data for Genmab A's Accounts Payables shows a peak YoY surged of 134.75% (in 2020) over the last 5 years.
  • Genmab A's Accounts Payables (Quarterly) stood at $7.2 million in 2019, then soared by 134.75% to $16.8 million in 2020.